上海交通大学学报(医学版) ›› 2017, Vol. 37 ›› Issue (9): 1220-.doi: 10.3969/j.issn.1674-8115.2017.09.006

• 论著(基础研究) • 上一篇    下一篇

下肢动脉超声筛查对 2 型糖尿病患者冠状动脉病变的提示价值

华笑寒,刘颖丰,曾辉,赵俊功,赵珺,刘芳,贾伟平   

  1. 上海市糖尿病临床医学中心,上海市“重中之重”代谢病临床医学中心,上海市糖尿病研究所,上海市糖尿病重点实验室,上海交通大学附 属第六人民医院内分泌代谢科,上海 200233
  • 出版日期:2017-09-28 发布日期:2017-10-10
  • 通讯作者: ?刘芳,电子信箱:f-liu@sjtu.edu.cn
  • 作者简介:华笑寒(1989—),女,硕士生;电子信箱:xhhua2009@hotmail.com
  • 基金资助:
    国家自然科学基(81270397);上海市教育委员会高峰高原学科建设计划(20152232)

Indicating value of lower extremity atherosclerotic disease ultrasound screening for cardiovascular diseases in type 2 diabetes patients#br#

HUA Xiao-han, LIU Ying-feng, ZENG Hui, ZHAO Jun-gong, ZHAO Jun, LIU Fang, JIA Wei-ping   

  1. Shanghai Clinical Medical Center of Diabetes; Shanghai Key Clinical Center of Metabolic Diseases; Shanghai Institute for Diabetes; Shanghai Key Laboratory of Diabetes; Department of Endocrinology and Metabolism, Sixth People’s Hospital, Shanghai Jiao Tong University, Shanghai 200233, China
  • Online:2017-09-28 Published:2017-10-10
  • Supported by:
    National Natural Science Foundation of China, 81270397; Shanghai Municipal Education Commission—Gaofeng Clinical Medicine Grant Support, 20152232

摘要: 目的 · 明确下肢动脉疾病超声筛查是否对2 型糖尿病患者的冠状动脉粥样硬化性心脏病(冠心病)有提示作用。方法 · 纳 入 606 例 2 型糖尿病住院患者,检测所有患者肝肾功能、糖代谢、肿瘤指标等生化指标,并进行下肢动脉超声和冠状动脉 CT 血管造 影(CTA)检查。根据动脉超声检查结果将患者分为合并糖尿病下肢动脉粥样硬化性病变(LEAD)组(n=318)及不合并 LEAD 组 (n=288);根据冠状动脉CTA 或经皮冠状动脉介入治疗(PCI)史或经皮冠状动脉腔内血管成形术(PTCA)史,分为合并冠心病组 (n=280)及不合并冠心病组(n=326)。分析不同下肢动脉病变患者的冠心病患病率及其相互关系。结果 · 2 型糖尿病患者冠心病患病 率随着下肢动脉病变加重而升高,其中下肢动脉硬化组冠心病的患病率为29%,斑块伴下肢动脉狭窄小于 50% 组冠心病的患病率为 63%,下肢动脉狭窄大于50% 或闭塞组冠心病的患病率为81%,后 2 组明显高于不合并LEAD 组(P=0.021, P=0.015)。 Spearman 相 关分析发现年龄、性别、糖尿病病程、收缩压、血清总胆固醇、下肢动脉病变、股动脉内中膜厚度与冠心病患病率呈正相关,而高密 度脂蛋白胆固醇、肾小球滤过率与冠心病患病率呈负相关。Logistic 回归分析进一步发现,糖尿病病程、下肢动脉病变与冠心病患病 率独立相关。校正年龄、糖尿病病程、血脂等影响因素后,动脉病变与冠心病的 OR 分析显示,下肢动脉病变患者的冠心病患病风险 提高4.818 倍 (OR=5.818,95% CI 为 2.627 ~ 12.888,P=0.000)。结论 · 下肢动脉超声显示的下肢动脉病变可提示冠状动脉病变患病 风险。

关键词: 糖尿病, 糖尿病血管并发症, 动脉粥样硬化, 下肢动脉病变, 冠状动脉粥样硬化性心脏病

Abstract:

Objective · To verify the indicating value of the simple screening of lower extremity atherosclerosis artery disease (LEAD) by lower extremity arterial ultrasound examination for coronary atherosclerotic heart disease (CAD) in patients with type 2 diabetes.  Methods · A total of 606 type 2 diabetes patients were enrolled. Their clinical data and biochemical parameters (hepatorenal function, glycometabolism, tumor markers) were collected. All patients were undertaken lower extremity vascular ultrasound and CT angiography (CTA) scan for coronary artery disease. According to the results of lower extremity ultrasound, patients were divided into two groups, patients with LEAD group (n=318) and patients without LEAD group (n=288). According to the history of coronary CTA or percutaneous coronary intervention (PCI) or percutaneous transluminal coronary angioplasty (PTCA), the patients were divided into CAD group (n=280) and non-combined CAD group (n=326). The prevalence of CAD in different LEAD groups was compared and their relationship was analyzed.  Results · The degree of LEAD was proportional to the prevalence of CAD. Both of the prevalences of CAD in group with arterial stenosis >50% (81%) and group with plaque and stenosis<50% (63%) were significantly higher than that in group without plaque (29%) (P=0.021, P=0.015, respectively). Spearman analysis found that age, sex, duration of diabetes, systolic blood pressure, total cholesterol, LEAD, femoral artery intima-media thickness were positively correlated with CAD. However, high density lipoprotein cholesterol and glomerular filtration rate were negatively associated with CAD. Logistic regression analysis revealed that duration of diabetes, existence of LEAD were independent associated factors of CAD. After adjusting the confounding factors, odds ratio risk analysis showed the risk increased 4.818 times in patients with LEAD (OR=5.818, 95% CI 2.62712.888, P=0.000).  Conclusion · The evaluation of LEAD by ultrasound has an indicating value for CAD in type 2 diabetes patients.

Key words: type 2 diabetes, diabetic vascular complication, atherosclerosis, lower extremity atherosclerotic disease, coronary atherosclerotic heart disease